146 related articles for article (PubMed ID: 3181291)
1. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
2. Subsensitivity to the cough-depressant effects of opioid and nonopioid antitussives in morphine-dependent rats: relationship to central serotonin function.
Kamei J; Mori T; Ogawa M; Kasuya Y
Pharmacol Biochem Behav; 1989 Nov; 34(3):595-8. PubMed ID: 2637700
[TBL] [Abstract][Full Text] [Related]
3. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
4. Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats.
Mueller RA; Towle AC; Breese GR
Brain Res; 1984 Apr; 298(2):370-3. PubMed ID: 6426700
[TBL] [Abstract][Full Text] [Related]
5. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
6. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective agonist of 5-HT1A receptors, on the cough reflex in rats.
Kamei J; Mori T; Igarashi H; Kasuya Y
Eur J Pharmacol; 1991 Oct; 203(2):253-8. PubMed ID: 1839282
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
8. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
9. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
Pranzatelli MR; Eng B
Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
[TBL] [Abstract][Full Text] [Related]
10. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
11. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
[TBL] [Abstract][Full Text] [Related]
12. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
13. Effects of L-tryptophan on the development of tolerance to the antitussive effects of dihydrocodeine.
Kamei J; Mori T; Kasuya Y
Jpn J Pharmacol; 1991 Mar; 55(3):403-6. PubMed ID: 1857028
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
[No Abstract] [Full Text] [Related]
15. Chemical denervation produces supersensitivity of central serotonergic receptors involved in the control of TSH secretion in the rat.
Schettini G; Di Renzo G; Amoroso S; Annunziato L; Quattrone A
Brain Res; 1983 Feb; 261(2):349-52. PubMed ID: 6831219
[No Abstract] [Full Text] [Related]
16. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
18. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
19. Effects of L-tryptophan on the effects of antitussives.
Kamei J; Mori T; Kasuya Y
J Pharmacobiodyn; 1990 Apr; 13(4):231-7. PubMed ID: 2384857
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
